JP2025502208A5 - - Google Patents
Info
- Publication number
- JP2025502208A5 JP2025502208A5 JP2024541809A JP2024541809A JP2025502208A5 JP 2025502208 A5 JP2025502208 A5 JP 2025502208A5 JP 2024541809 A JP2024541809 A JP 2024541809A JP 2024541809 A JP2024541809 A JP 2024541809A JP 2025502208 A5 JP2025502208 A5 JP 2025502208A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- indole
- ethane
- bis
- amine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263299599P | 2022-01-14 | 2022-01-14 | |
| US63/299,599 | 2022-01-14 | ||
| US202263384704P | 2022-11-22 | 2022-11-22 | |
| US63/384,704 | 2022-11-22 | ||
| PCT/EP2023/050702 WO2023135237A1 (en) | 2022-01-14 | 2023-01-13 | Tryptamine compositions and methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025502208A JP2025502208A (ja) | 2025-01-24 |
| JP2025502208A5 true JP2025502208A5 (https=) | 2026-01-20 |
Family
ID=85018123
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024541809A Pending JP2025502208A (ja) | 2022-01-14 | 2023-01-13 | トリプタミン組成物および方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250051279A1 (https=) |
| EP (1) | EP4463440A1 (https=) |
| JP (1) | JP2025502208A (https=) |
| KR (1) | KR20240134951A (https=) |
| AU (1) | AU2023207801B2 (https=) |
| CA (1) | CA3259235A1 (https=) |
| IL (1) | IL313889A (https=) |
| MX (1) | MX2024008691A (https=) |
| WO (1) | WO2023135237A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024108195A1 (en) | 2022-11-17 | 2024-05-23 | Remedi, Inc. | Combinations of monoamine oxidase inhibitors and serotonin receptor agonists and their therapeutic use |
| WO2026013174A1 (en) | 2024-07-10 | 2026-01-15 | Cybin Uk Ltd | Pharmaceutical compositions comprising deuterated n,n-dimethyltryptamine |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5612059A (en) | 1988-08-30 | 1997-03-18 | Pfizer Inc. | Use of asymmetric membranes in delivery devices |
| US5798119A (en) | 1995-06-13 | 1998-08-25 | S. C. Johnson & Son, Inc. | Osmotic-delivery devices having vapor-permeable coatings |
| ID28302A (id) | 1999-01-14 | 2001-05-10 | Teijin Ltd | Alat untuk mengumpankan suatu bubuk dalam jumlah tertentu |
| GB0114272D0 (en) | 2001-06-12 | 2001-08-01 | Optinose As | Nasal delivery device |
| CN1736502A (zh) | 1999-03-03 | 2006-02-22 | 奥普蒂诺斯公司 | 鼻传送装置 |
| GB0121568D0 (en) | 2001-09-06 | 2001-10-24 | Optinose As | Nasal delivery device |
| GB0019715D0 (en) | 2000-08-10 | 2000-09-27 | Pa Consulting Services | Device for delivering physiologically active agent in powdered form |
| ZA200306564B (en) | 2001-02-26 | 2004-10-15 | Optinose As | Nasal devices. |
| WO2003026559A2 (en) | 2001-09-28 | 2003-04-03 | Kurve Technology, Inc | Nasal nebulizer |
| GB0207422D0 (en) | 2002-03-28 | 2002-05-08 | Optinose As | Nasal devices |
| GB0207817D0 (en) | 2002-04-04 | 2002-05-15 | Optinose As | Nasal devices |
| GB0209494D0 (en) | 2002-04-25 | 2002-06-05 | Optinose As | Nasal devices |
| US7267121B2 (en) | 2004-04-20 | 2007-09-11 | Aerogen, Inc. | Aerosol delivery apparatus and method for pressure-assisted breathing systems |
| US12240813B2 (en) * | 2020-05-19 | 2025-03-04 | Cybin Irl Limited | Deuterated tryptamine derivatives and methods of use |
| WO2021234608A1 (en) * | 2020-05-19 | 2021-11-25 | Cybin Irl Limited | Deuterated tryptamine derivatives and methods of use |
| EP3902541B1 (en) * | 2020-06-02 | 2022-09-14 | Small Pharma Ltd | Therapeutic compositions comprising deuterated or partially deuterated n,n-dimethyltryptamine compounds |
| US12042564B2 (en) * | 2020-06-02 | 2024-07-23 | Cybin Uk Ltd | Therapeutic solid dosage forms |
| RU199823U1 (ru) | 2020-06-10 | 2020-09-21 | Общество С Ограниченной Ответственностью "Центр Передовых Радиационных Медицинских И Биологических Технологий | Устройство для лечения бронхолегочных заболеваний |
| EP4221682A2 (en) * | 2020-10-02 | 2023-08-09 | Cybin IRL Limited | Methods for delivery of psychedelic medications by inhalation and systems for performing the methods |
| EP4031529B1 (en) * | 2020-12-01 | 2023-09-27 | Small Pharma Ltd | Deuterated or partially deuterated n,n-dimethyltryptamine compounds |
-
2023
- 2023-01-13 EP EP23700949.3A patent/EP4463440A1/en active Pending
- 2023-01-13 US US18/720,922 patent/US20250051279A1/en active Pending
- 2023-01-13 CA CA3259235A patent/CA3259235A1/en active Pending
- 2023-01-13 AU AU2023207801A patent/AU2023207801B2/en active Active
- 2023-01-13 JP JP2024541809A patent/JP2025502208A/ja active Pending
- 2023-01-13 IL IL313889A patent/IL313889A/en unknown
- 2023-01-13 KR KR1020247026687A patent/KR20240134951A/ko active Pending
- 2023-01-13 MX MX2024008691A patent/MX2024008691A/es unknown
- 2023-01-13 WO PCT/EP2023/050702 patent/WO2023135237A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025502208A5 (https=) | ||
| JP2024533291A5 (https=) | ||
| JP2024540282A5 (https=) | ||
| JP2023526856A5 (https=) | ||
| TW200811116A (en) | Compounds | |
| JPH11106341A (ja) | ３−（５−テトラゾリル−ベンジル）アミノ−ピペリジン誘導体を含む医薬組成物 | |
| TW201002682A (en) | Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine | |
| CN100352437C (zh) | 哌嗪衍生物、它们的制备方法及其在制备治疗中枢神经系统(cns)疾病的药物中的应用 | |
| PT885220E (pt) | Derivados de tropano a sua preparacao e utilizacao | |
| AU1037897A (en) | 3-benzylaminopyrrolidines and -piperidines as tachykinin receptor antagonists | |
| JP2023539113A5 (https=) | ||
| JP2025505745A5 (https=) | ||
| JP2024522065A5 (https=) | ||
| WO2003035599A1 (en) | Quarternary ammonium compounds and their use as antimuscarinic agents | |
| JPH05230059A (ja) | ベンゾジオキサン誘導体 | |
| JP2009526814A (ja) | 鏡像異性的に純粋なキヌクリジニルオキシピリダジン、及びニコチン性アセチルコリン受容体リガンドとしてのその使用 | |
| JP2008535848A5 (https=) | ||
| CN102070631B (zh) | 戊乙奎醚光学异构体的季铵盐、药物组合物及其医药用途 | |
| WO2016101898A1 (zh) | 3-[(苯并[d][1，3]二氧戊环-4-基)-氧基]-3-芳基丙胺类化合物及其应用 | |
| JP4861979B2 (ja) | テトラヒドロイソキノリンスルホンアミド誘導体、その調製及び治療における同誘導体の使用 | |
| ES2232132T3 (es) | Derivados de indolil como agentes serotoninergicos. | |
| CN104610195A (zh) | 沃替西汀的天冬氨酸盐或其水合物及其制备方法和用途 | |
| CN1856471A (zh) | 3－苯基磺酰基－8－哌嗪－1－基－喹啉的多晶型物 | |
| JP2001522847A (ja) | ピペリジン誘導体およびそれらのタキキニン拮抗物質としての使用 | |
| CN1202164A (zh) | 二芳基链烯基胺衍生物 |